COX-2s May Be Grouped With NSAIDs In Model Medicare Formulary
Executive Summary
COX-2 inhibitors may be included as part of the broader NSAID category in the model Medicare formulary under development by the U.S. Pharmacopeia
You may also be interested in...
USP Medicare Formulary Design Committee To Host Public Meeting Aug. 27
The U.S. Pharmacopeia's expert committee on Medicare model guidelines will hold a public meeting Aug. 27 in Baltimore to discuss the design of the formulary template for the new outpatient prescription drug benefit
USP Medicare Formulary Design Committee To Host Public Meeting Aug. 27
The U.S. Pharmacopeia's expert committee on Medicare model guidelines will hold a public meeting Aug. 27 in Baltimore to discuss the design of the formulary template for the new outpatient prescription drug benefit
Medicare Rx Formulary Will Have More Than VA’s 30 Classes
The Medicare Part D model formulary will have more than the 30 therapeutic drug classes included in the Veterans Affairs formulary, Centers for Medicare & Medicaid Services Administrator Mark McClellan said at a National Health Council Medicare briefing in Washington, D.C. July 15